June 6, 2017August 24, 2022
University of Michigan Researchers Identify 16 New Genetic Markers That Shed Light on Psoriasis
News
University of Michigan researchers have shed more light on the genetic landscape behind the intricate mechanisms of psoriasis. The 16 ... Read more
June 1, 2017
OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany
News
One World Cannabis Pharmaceutical Research (OWCP) and mediq Innovation Experts have partnered to introduce OWCP’s cannabinoid-based topical psoriasis cream in Germany. ... Read more
May 30, 2017May 30, 2017
FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis
News
The U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) for Sun Pharmaceutical’s lead investigational drug tildrakizumab ... Read more
May 25, 2017May 25, 2017
Janssen’s Phase 3 Trials for Guselkumab to Focus on Plaque Psoriasis, Psoriatic Arthritis
News
Janssen announced two new Phase 3 clinical trials for psoriasis for its investigational drug guselkumab. The company intends to explore ... Read more
May 23, 2017
Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests
News
Patients taking Remicade (infliximab) can safely switch to treatment with biosimilar CT-P13, sold as Pfizer’s Inflectra and Celltrion Healthcare’s Remsima, according to ... Read more
May 16, 2017May 16, 2017
Cannabinoids Have Potential to Treat Skin Conditions Like Psoriasis, Review Shows
News
Compounds extracted from the cannabis plant (cannabinoids) have therapeutic proprieties that could be used to treat several skin conditions, including psoriasis, ... Read more
May 11, 2017
Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target
News
An already started Phase 2b clinical trial of Prurisol as a treatment for moderate-to-severe chronic plaque psoriasis has recruited more than 70 ... Read more
May 9, 2017
Pfizer’s Xeljanz Reduced Nail Psoriasis in Phase 3 Trials of Plaque Disease
News
Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib) was effective against nail psoriasis in patients with plaque disease, according to data from ... Read more
May 4, 2017May 4, 2017
FDA Accepts Pfizer’s Supplemental New Drug Application for Xeljanz to Treat Active Psoriatic Arthritis Patients
News
The U.S. Food and Drug Administration (FDA) will review Pfizer’s medication Xeljanz (tofacitinib citrate) 5 mg twice daily, to treat adults with ... Read more
May 2, 2017
Cimzia and Cosentyx Approved to Treat Active Psoriatic Arthritis in England and Wales
News
The U.K.’s National Institute for Health and Care Excellence (NICE) has approved the use of Cimzia (certolizumab pegol) and Cosentyx (secukinumab), ... Read more
April 27, 2017April 27, 2017
Valeant Prices Plaque Psoriasis Treatment, Siliq, at $3,500 a Month
News
Siliq (brodalumab) injection, recently approved to treat adults with severe plaque psoriasis, will be available in the U.S. at a ... Read more
April 20, 2017April 20, 2017
XTRAC Light Therapy Effectively Treats Psoriasis Lesions Without the Serious Side Effects of Rival Therapies, Says Strata
News
XTRAC targeted-light therapy safely treats skin lesions in psoriasis patients without the serious side effects linked to Humira and other conventional psoriasis drugs, ... Read more

November 29, 2016November 29, 2016

Regen BioPharma Advances Small Molecule Program for Psoriasis, Cancer, Other Diseases

News

Following the recent completion of preliminary studies of its NR2F6 small molecule modulators, Regen BioPharma will now move to understand the mechanisms of action and optimize its compounds for the ... Read more

November 22, 2016

Galectin Encouraged by Early Clinical Results for Treating Two Skin Diseases

News

Galectin Therapeutics has announced positive data for its galectin-3 inhibitor GR-MD-02, for treating serious skin diseases like moderate-to-severe plaque psoriasis and severe atopic dermatitis. Galectin is now planning to identify ... Read more

November 18, 2016November 18, 2016

Potential Topical Treatment for Psoriasis Shows Promise in Preclinical Studies

News

Samumed recently presented positive data from preclinical studies of SM04755 as a potential topical treatment of psoriasis. Preclinical in vitro and in vivo studies, presented at the 2016 American College of Rheumatology (ACR) Annual ... Read more

November 10, 2016

Phototherapy Appears to Improve Psoriasis, Study Shows

News

Narrowband UVB light therapy (phototherapy) can improve psoriasis in patients by decreasing the levels of a protein called MMP-2, which contributes to the pathology of this disease, according to a ... Read more

November 8, 2016November 8, 2016

FDA Approves Enbrel as First Biologic Treatment for Children with Plaque Psoriasis

News

The U.S. Food and Drug Administration (FDA) has agreed to the expanded use of Enbrel (etanercept) to treat children with chronic moderate-to-severe plaque psoriasis, making Amgen’s biologic the first systematic therapy approved for pediatric patients ... Read more

November 3, 2016November 3, 2016

Troubled Genetic Pathways Linked to Psoriasis Seen to Respond to Humira Treatment

News

Researchers identified abnormal genetic pathways associated with psoriasis, some of which may be restored after treatment with Humira (adalimumab), according to a new study published in the journal BMC Genomics. In the ... Read more

November 2, 2016

NOR-SWITCH Study Shows It’s OK to Switch from Remicade to Biosimilar Inflectra

News

Patients taking Remicade (infliximab) can safely switch to its biosimilar drug Inflectra (CT-P13), according to results from the NOR-SWITCH study, presented at UEG (United European Gastroenterology) Week 2016, in Vienna, Austria. ... Read more

October 27, 2016

Otezla Receives Key NICE Recommendation for Adult Patients with Chronic Plaque Psoriasis in England, Wales

News

The National Institute for Health and Care Excellence (NICE) has issued a positive final appraisal recommending the use of Celgene’s Otezla (apremilast) for adult patients with chronic plaque psoriasis in ... Read more

October 25, 2016October 25, 2016

People Hospitalized for Psoriasis and Atopic Dermatitis Both at Higher Risk of Dying, Study Reports

News

Patients hospitalized for atopic dermatitis were less likely to die in the 10 years they were followed by researches than those hospitalized for psoriasis, but people with either disease were seen to have much ... Read more

University of Michigan Researchers Identify 16 New Genetic Markers That Shed Light on Psoriasis

OWCP and mediq Collaborate to Introduce Cannabinoid-based Psoriasis Cream in Germany

FDA Approves BLA Filing for Sun Pharma’s Lead Candidate Therapy Tildrakizumab to Treat Plaque Psoriasis

Janssen’s Phase 3 Trials for Guselkumab to Focus on Plaque Psoriasis, Psoriatic Arthritis

Remicade Can Be Substituted for Less Expensive Biosimilar CT-P13, Clinical Trial Suggests

Cannabinoids Have Potential to Treat Skin Conditions Like Psoriasis, Review Shows

Phase 2b Trial of Psoriasis Therapy Prurisol Reaches 70% of Participant Target

Pfizer’s Xeljanz Reduced Nail Psoriasis in Phase 3 Trials of Plaque Disease

FDA Accepts Pfizer’s Supplemental New Drug Application for Xeljanz to Treat Active Psoriatic Arthritis Patients

Cimzia and Cosentyx Approved to Treat Active Psoriatic Arthritis in England and Wales

Valeant Prices Plaque Psoriasis Treatment, Siliq, at $3,500 a Month

XTRAC Light Therapy Effectively Treats Psoriasis Lesions Without the Serious Side Effects of Rival Therapies, Says Strata